|Year : 2020 | Volume
| Issue : 1 | Page : 1
Editor's Page January 2020
Ravi R Kasliwal MD, DM, FIMSA, MNAMS, FASE
Editor-in-Chief, Journal of Clinical and Preventive Cardiology, Gurgaon, Haryana, India
|Date of Web Publication||16-Mar-2020|
Dr. Ravi R Kasliwal
Clinical and Preventive Cardiology, Medanta - The Medicity, Sector 38, Gurgaon, Haryana - 122 001
Source of Support: None, Conflict of Interest: None
|How to cite this article:|
Kasliwal RR. Editor's Page January 2020. J Clin Prev Cardiol 2020;9:1
As April approaches, the quantum of work at the Medanta Heart Institute increases exponentially because of our Annual Meeting ”Medanta Echo n Cardiology: Today and Tomorrow,” scheduled to be organized on ”April 18 and 19, 2020.” The Theme this year is appropriately ”Unraveling the Complex Clinical Cardiovascular Conundrum.” This is the 9th edition of this conference which has delegates from across India and also the SAARC countries.
An original article from Nigeria, ”Total cardiovascular risk assessment of women in Delta State, Nigeria, using the World Health Organization/International Society of Hypertension risk prediction chart,” clearly demonstrates that increasing age and lower educational status are related to increasing strokes and myocardial infarctions in women in Nigeria. The study again brings into focus the menace of noncommunicable diseases worldwide, as also in the African continent, in women. The authors rightly comment, ”reducing cardiovascular risk portends a more promising strategy for cutting down mortality rates than interventions targeted at the treatment of already established disease.”
Another article from Nigeria, ”Baseline high-sensitive cardiac troponin I as a predictor of fatality in stable chronic heart failure patients in Nigeria,” talks about troponin I as a predictive of heart failure fatality. This is an elegant study though the numbers are small. Still, reproducing these findings in developing/under-developed nations is important because heart failure burden is high, whereas the epidemiology is quite different from the developed western nations.
From Puducherry comes an original article on physical inactivity titled, ”Are the urban slum population physically inactive? A descriptive study from urban Puducherry.” As is well documented, inactivity is a risk factor for noncommunicable diseases globally. This study showed that three out of every four adults were physically inactive, which is a matter of great concern. However, even more concerning is the finding that physical inactivity was more prevalent among young adults. Sadly, this is the reflection for our country which already has a huge burden of noncommunicable diseases.
Dr. Rajesh Nepal et al. from Biratnagar, Nepal, in an original contribution titled, ”Prevalence, major cardiac causes of cardioembolic stroke and in-hospital mortality in Eastern Nepal” conclude that ”hypertension and dyslipidemia were the most prevalent conventional risk factors, while atrial fibrillation was the most common cardiac cause of cardioembolic stroke.” This only goes to show how control of conventional cardiovascular risk factors can save many lives.
In patients receiving coumadin derivatives for various indications, monitoring the dose of anticoagulants has been a major challenge. The high variability of the prothrombin time test and the lack of standardization lead to uncertain diagnostic accuracy of various laboratories, with resultant catastrophic consequences. Point-of-care testing, if proven accurate, could be a very good solution to this problem. Dr. Raghuram Palaparti et al. from Andhra Pradesh, India, in an article titled, ”Comparison of prothrombin time and international normalized ratio values using point-of-care system with a standardized laboratory method in patients on long-term oral anticoagulation: A prospective study,” demonstrate good accuracy of one such point-of-care test for an international normalized ratio. This is a welcome finding as it enables patients to easily and reliably monitor and manage their anticoagulation therapy.
An interesting case report, ”Percutaneous intervention in thrombotically occluded grafted renal artery,” from Dr. Devendra Borgaonkar et al. highlights rare but dreaded vascular complications of renal allograft-transplant thrombosis and occlusion of a grafted renal artery. It also shows a keen and close association between the two departments and, of course, the value of early clinical diagnosis.
Finally, landmark trials so-vividly captured by Dr. Rahul Mehrotra make for very interesting reading. Some of the articles are really worth reflecting on a larger perspective.
I do hope dear reader, you will like this issue of JCPC. Send in your views at email@example.com.
Happy, prosperous, scientifically stimulating 2020 to you.